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Quorum sensing (QS) coordinates the expression of multiple virulence factors in
Pseudomonas aeruginosa; hence its inhibition has been postulated as a new alternative
to treat its infections. In particular, QS interference approaches claim that they attenuate
bacterial virulence without directly decreasing bacterial growth and suggest that in vivo
the immune system would control the infections. Moreover, since in vitro experiments
performed in rich medium demonstrate that interfering with QS decreases the production
of virulence factors without affecting bacterial growth it was assumed than in vivo
therapies will minimize the selection of resistant strains. Therefore, the underlying
assumptions toward an effective implementation of a successful Quorum sensing
interference (QSI) therapy for treating P. aeruginosa infections are that (i) QS only exerts
important effects in the regulation of virulence genes but it does not affect metabolic
processes linked to growth, (ii) the expression of virulence factors is only positively
regulated by QS, (iii) inhibition of virulence factors in vivo do not affect bacterial growth, (iv)
the immune system of the infected patients will be able to get rid of the infections, and
(v) the therapy will be effective in the strains that are actively producing the infections.
Nevertheless, for QSI in P. aeruginosa, substantial experimental evidence against the
validity of most of these assumptions has accumulated during the past years, suggesting
that a far better understanding of its virulence and its behavior during infections is needed
in order to design truly solid QSI therapeutic alternatives to combat this remarkable
pathogen.
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INTRODUCTION
Pseudomonas aeruginosa is a remarkable opportunistic pathogen that infects patients that are
immunocompromised, have severe burns, cancer, or AIDS, are intubated and with prosthetic
devices, and also those suffering from chronic affections like cystic fibrosis (CF). This bacterium
is a major health problem worldwide being responsible of 10% of nosocomial infections (Antunes
et al., 2010; Castillo-Juárez et al., 2015), since it is intrinsically resistant to several antimicrobials
(Poole, 2011) and able to develop resistance against new ones, has a high biofilm production and
produces an arsenal of virulence factors. One of the main mechanisms that controls the production
of its virulence factors is quorum sensing (QS) which coordinates the expression of such factors
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once bacteria have reached a high population density, thus
maximizing their chances to overcome the host defenses and
establish the infection.
QS systems are common in bacterial pathogens; among Gram
negatives, in addition to P. aeruginosa, Acinetobacter baumannii
(Bhargava et al., 2010), Escherichia coli (Sperandio et al., 2002)
Salmonella strains (Choi et al., 2007), and Vibrio strains (Zhu
et al., 2002; Yang andDefoirdt, 2015) use them to coordinate their
virulence. Hence, QS interference (QSI) or quorum quenching
(QQ) is a strategy proposed to inhibit virulence as an alternative
to treat the infections of several important bacterial pathogens
(Castillo-Juárez et al., 2015).
In this opinion piece I focus in P. aeruginosa, one of the most
studied organisms regarding QS and QSI, nevertheless what is
exposed here may be also applicable to other bacterial pathogens.
P. aeruginosa is one of the more complex known bacterial
pathogens; it possesses an ample genome and a high percentage
of its genes are devoted to gene regulation (Stover et al., 2000).
Regarding QS systems, it has a hierarchical architecture governed
by the LasRI module which produces and senses N-3-oxo-
dodecanoyl-L-Homoserine lactone and activates the expression
of multiple virulence genes such as those producing elastase
A and B, pyocyanin, alkaline and protease, and activating a
second homoserine lactone (HSL) QS module known as RhlRI,
which produces and senses N-butyryl-L-Homoserine lactone.
RhlR bound to its autoinducer also activates directly some
virulence genes like those encoding rhamnolipids and pyocyanin
(Smith and Iglewski, 2003; Jimenez et al., 2012). In addition,
P. aeruginosa also has a quinolone dependent system known as
PQS, which is positively regulated by LasR and negatively by
RhlR, forming a complex and intricate network (Jimenez et al.,
2012; Lee and Zhang, 2015). In addition to the QS intrinsic
components, several regulators such as GacA/GacS, QscR, Vfr,
RpoN, and RpoS, influence the expression of QS dependent
factors (Lee and Zhang, 2015).
The complex relationship between QS and virulence in
P. aeruginosa had been recently evidenced by the fact that lasR
deficient mutants (including clinical strains) growing at slow
rates or in the stationary phase, overproduce pyocyanin due a
lack of repression of the phenazine genes by RsaL, a negative
transcriptional regulator positively controlled by LasR (Cabeen,
2014). Moreover, in lasRmutants, the activity of the rhl system is
only delayed but not abolished, allowing significant production of
pyocyanin, rhamnolipids and N-butyryl-L-Homoserine lactone
(which are RhlR dependent) and even the production of the
LasR dependent QS signals N-3-oxo-dodecanoyl-L-Homoserine
lactone and PQS (Dekimpe and Deziel, 2009). These findings
suggest that the inhibition of a particular component of the QS
network, even the pivotal factor LasR, may be counteracted by
the activation of alternative components of the network. Indeed,
some recent studies have identified novel QS inhibitors for which
RhlR and not LasR as the relevant in vivo target (O’Loughlin et al.,
2013; Welsh et al., 2015).
In addition, recently it was discovered that an environmental
strain (148 isolated from dolphin gastric juice) produces
significant amounts of the QS-controlled virulence factors
rhamnolipids and pyocyanin. Critically, this strain is virulent
to mice, even without having a lasR gene and without
producing N-3-oxo-dodecanoyl-L-Homoserine lactone. Hence,
in this strain, the control of QS dependent virulence factors must
be exerted by other regulators (Grosso-Becerra et al., 2014).
QS Interference could be achieved by the attenuation of
the QS communication systems via: (i) the disruption of the
QS receptors, (ii) the degradation of the autoinducers signals
or (iii) the inhibition of the signal synthesis. Accordingly,
several QS inhibitors or quorum quenchers (QQ) suitable for
P. aeruginosa have been developed, under the assumptions that
(i) the expression of virulence factors is only positively regulated
by QS, (ii) the QQ will only exert significant effects in the
regulation of virulence genes but not in metabolic processes
linked to growth, hence avoiding or at least decreasing the
generation of selective pressure that leads to resistance, (iii) the
immune system of the infected patients will be able to get rid of
the infections, and (iv) the therapy will be effective against the
strains that are actively producing the infections. Nevertheless,
substantial evidence against the validity of those assumptions has




Although the role of QS in P. aeruginosa virulence has been
extensively studied, whether it influences global metabolism
and cell growth is less explored. One possible reason for this
bias is that at the transcriptomic level, few significant changes
in metabolicrelated genes are found when QS proficient and
deficient strains are compared or when QS inhibitors are
administrated to QS proficient strains (Hentzer et al., 2003;
Schuster et al., 2003; Wagner et al., 2003). Nevertheless, recently
Davenport and coworkers found that the metabolome of a lasI
rhlI double mutant (unable to produce HSL QS autoinducers)
and that of its wild-type progenitor have a notorious divergence
once the wild-type strain produced the highest levels of
autoinducers; remarkably, around one third of all the metabolites
identified changed (Davenport et al., 2015). This phenomenon
is understandable since the wild-type strain devotes many of
its resources to the production of costly virulence factors such
as exoproteases, phenazines, and exopolysacharides, while, in
contrast, the QSmutants uses the same resources for cell division.
In agreement, the QS deficient mutants achieve higher growth
yields than QS wild-type strains (Diggle et al., 2007).
Although the possible implications of the metabolic
divergence in QS mutants on bacterial physiology and QS
interference therapies is still unexplored, Davenport and
coworkers demonstrated that important metabolic changes in
the membrane metabolism of the wild-type strain are driven
by QS upon entering the stationary phase. These modifications
include increased fatty acid saturation, chain length, and
cyclopropanation, which in turn, promote the generation of
robust cell membranes. In contrast, the membranes of QS
mutants do not have these modifications and are therefore more
susceptible to stress.
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In addition to these metabolic changes, several works have
demonstrated that in P. aeruginosa and other bacteria, QS
enhances the stress response (Bjarnsholt et al., 2005; Bhargava
et al., 2014; de Oca-Mejia et al., 2015; García-Contreras et al.,
2015a); for example, by upregulating antioxidant enzymes such
as catalase, superoxide dismutase (Hassett et al., 1999) and
NADPH-generating enzymes (García-Contreras et al., 2015a).
This is important since during an infection, the immune system
attacks bacteria by releasing reactive oxygen species, and at least
in vitro oxidative stress is able to select functional QS systems as
well as QS interference resistant mutants (García-Contreras et al.,
2015a).
Moreover, growth of P. aeruginosa can be strongly dependent
on QS either if adenosine or protein is used as sole carbon
sources, since nuh, the gene encoding the nucleoside hydrolase,
is under tight LasR control (Heurlier et al., 2005) and since
the expression of exoproteases is under QS control (Diggle
et al., 2007). During infections, adenosine utilization (Patel et al.,
2007; Sheng et al., 2012) as well as the degradation of host
proteins (Wretlind and Pavlovskis, 1983; Laarman et al., 2013)
are important for bacterial virulence and survival.
All the above summarized facts demonstrate that QS is an
important regulator of bacterial metabolism and physiology
and suggest that QS interference will have the direct effect of
decreasing bacterial growth and viability in vivo. In agreement,
several in vivo infection studies have shown that when a QS
interference therapy is able to increase animal survival (and
decrease damage to the host), there is a significant decrease
in bacterial counts in the infection sites (Wu et al., 2004;
Christensen et al., 2007; Defoirdt et al., 2010; Jakobsen et al.,
2011). The decrease in bacterial viability due QS interference may
be an important potential source of in vivo selective pressure
for the selection of bacterial resistance (García-Contreras et al.,
2016).
POTENTIAL INCREASE IN VIRULENCE
UPON QUORUM SENSING
INTERFERENCE
Although the production of multiple virulence factors in
P. aeruginosa is positively regulated by QS, the virulence
phenotype displayed by this organism is a complex combinatorial
phenomenon that cannot be easily predicted with the
identification of the presence or absence of a set of specific genes
(Lee et al., 2006; Grosso-Becerra et al., 2014). In agreement,
several studies had shown that clinical strains display a wide
variety levels of virulence (Fenner et al., 2006; Lee et al., 2006;
Garcia-Contreras et al., 2015b) and that environmental strains
often conserve high virulence (Grosso-Becerra et al., 2014).
An overlooked fact about the role of QS in P. aeruginosa
virulence was discovered in 2005 by Bleves and coworkers,
who that found that in contrast to several other virulence
traits, the expression of the type III secretion system (TTSS) in
P. aeruginosa is negatively regulated by QS, specifically by RhlR
and PqsR (Bleves et al., 2005; Kong et al., 2009). An important
factor in such negative regulation of virulence genes by QS is that
it requires low calcium levels, and hence several transcriptomics
studies done in culture medium such as LB with relative high
calcium levels fail to show this relationship. Since the TTSS
is an important determinant of virulence in several animal
infection models including pneumonia, peritonitis, bacteremia,
burn infections, and keratitis (Hauser, 2009), the possibility
that QS interfering therapies may be activating this system and
therefore promoting virulence should not be ignored. Moreover,
P. aeruginosa has five of the six known types of secretion systems
present in Gram negative bacteria (all but type IV) and some
of these systems, like type VI, are present in several copies
in its genome (Bleves et al., 2010). The QS influence on the
expression of these secretion systems is as of yet unknown, with
the exceptions of the TTSS and the second type VI secretion
system that are negatively regulated by QS (Sana et al., 2012).
More striking is the fact that QS interference using
azithromycin selects the wild-type virulent phenotype against
the less virulent lasR mutants in intubated patients colonized
by P. aeruginosa (Kohler et al., 2010). This surprising fact is
understandable since lasR mutants often appear and are selected
in infections since they act as phenotypic cheaters that utilize the
public goods such as exoproteases and siderophores produced by
the cooperative wild-type individuals (Diggle et al., 2007; Sandoz
et al., 2007). Hence, inhibiting QS removes the advantage of the
lasRmutants and thereby selects the wild-type, thus a detrimental
effect of QS interference in the long run could be to increase the
prevalence of virulent genotypes in the nosocomial environment
(Kohler et al., 2010).
Another key aspect of current QS inhibitors like furanones is
that, depending on their concentration, they can activate rather
than inhibit QS (Martinelli et al., 2004). Furthermore, related QS
inhibitors such as synthetic HSLs can activate rather than inhibit
some virulence factors (Welsh et al., 2015).
LIMITATIONS OF THE CURRENT ANIMAL
INFECTION MODELS FOR THE STUDY OF
QUORUM SENSING INTERFERENCE
To date, several animal infection models have demonstrated
that QS deficient mutants are much less virulent than their
QS proficient parental strains; accordingly, QS interference
promotes an increase in host survival and a decrease in
damage and bacterial counts (Castillo-Juárez et al., 2015). The
infection models used include arthropods likeGalleria mellonela,
nematodes such as Caenorhabditis elegans, fruit fly, and zebrafish
which are valuable and informative but that do not accurately
reflect human physiology. Moreover, when mice are used as a
model, immune competent individuals are evaluated; hence, the
fact that P. aeruginosa is a strict opportunistic pathogen that
does not attack individuals with competent immune systems
is overlooked, and so it is not clear if the immune systems of
immunosuppressed patients will be able to clear the bacteria from
infections upon QS interference treatments.
In addition to attacking immunosupressed individuals,
P. aeruginosa is the major cause of death of CF patients;
accordingly, there are several mice models that incorporate
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different mutations in the CF transmembrane conductance
regulator (CTFR) protein and that are able to mimic some of the
characteristics of the disease in humans. However, CF is a very
complex disease and there are more than one thousand reported
mutations in the cftr gene associated with the disease; hence,
developing a murine model that closely resembles the human
disease is challenging (Guilbault et al., 2007).
Most of the current models are suitable to study acute
infections and only a few like the one developed in 2005 by
Hoffmann and coworkers are optimized to simulate chronic CF
infections (Hoffmann et al., 2005). Importantly, this model has
been used to demonstrate that QS interference with azithromycin
inhibits alginate production of the mucoid NH57388A strain
in vivo, attenuating the damage produced to the host, but
unfortunately it was not able to significantly increase mouse
survival (Hoffmann et al., 2007).
Clinical studies have demonstrated that AZM treatment
improves lung function in CF patients (Saiman et al., 2003);
however, besides the QSI effect, azithromycin has bactericidal
and anti-inflammatory effects; hence, the improvement of both
mice and patients is likely due a combination of these effects
rather than an exclusive consequence of the QSI properties of
azithromycin. Therefore, testing of the effect of more specific QS
interference molecules in these kind of models is needed in order
to elucidate the potential of these therapies for CF patients.
Another kind of mouse model that more closely resembles
the situation observed in humans is the thermally-induced injury
model, which consists of producing a burn of second or third
degree on the dorsal side of the mouse using hot water and
subsequent inoculation of the burn. The utilization of this model
has confirmed that QS-deficient mutants such as lasR, lasI, rhlI,
lasI rhlI, and pqsA (Rumbaugh et al., 1999a,b; Lesic et al., 2007),
have less virulence than the parental strains. Moreover, it has
been used to test the effect of the halogenated anthranilic acid
analogs 6FABA, 6CABA, and 4CABA which are inhibitors of
the synthesis of quinolone QS signals. These compounds, at
the doses administrated, decrease mouse mortality significantly.
Nevertheless, they were tested at a single dose (Lesic et al.,
2007), so it is unknown if they exert dose response effects.
This is not trivial since as mentioned before, QS inhibitors
may act as QS activators depending on the used doses
(Martinelli et al., 2004).
INSENSIBILITY OF SOME CLINICAL
STRAINS TO CURRENT QUORUM
QUENCHERS
Before 2010 it was assumed than QS interference will be
impervious or at least less susceptible to promote bacterial
resistance than conventional antibiotic therapies (Defoirdt et al.,
2010). In 2011, it was demonstrated that P. aeruginosa acquires
resistance easily against the canonical HSL-dependant quorum
quencher furanone C-30, by activating the multidrug eﬄux
pump MexAB-OprM (Maeda et al., 2012). The activation of this
pump is mediated by mutations disrupting the transcriptional
repressors MexR and NalC, and such mutations are common in
clinical isolates, presumably since they are selected by intense
antibiotic treatments (Tomas et al., 2010). As expected, these
clinical isolates are resistant against C-30 (Maeda et al., 2012).
Recent studies have demonstrated that C-30 resistance is
common in multidrug resistant strains. Importantly, resistance
against other QQ compounds like 5-fluorouracil is also present in
some clinical isolates and some antibiotic sensitive strains are also
resistant to C-30 by a decrease in the compound uptake. More
strikingly, some of these strains produce higher amounts of the
virulence factors in the presence of the furanone than in basal
conditions (García-Contreras et al., 2013a,b; Garcia-Contreras
et al., 2015b).
This suggests that if eventually QSI therapies are implemented
in the clinic, they likely would not be effective against all the
strains present in infections (García-Contreras et al., 2013a; Kalia
et al., 2013), and that crucially they may fail to inhibit those
strains with active antibiotic eﬄux pumps. Indeed, it was recently
proposed that bacteria resistant to several QS inhibitors may be
selected by QSI treatments (Koul et al., 2016).
PERSPECTIVES
Since recent evidence has demonstrated that QS is linked
to basal metabolism and growth, it will be important to
evaluate QS interference and its effect in bacteria growing in
medium that more closely simulates the composition of the
environment during infection (Palmer et al., 2007; Garcia-
Contreras et al., 2015b), with attention on key metabolites
that influence virulence and QS such as iron (Sokol and
Woods, 1984; Mittal et al., 2008; Hazan et al., 2010), calcium
(Sarkisova et al., 2005), phosphate (Zaborin et al., 2009), and
adenosine (Patel et al., 2007; Sheng et al., 2012). Further,
metabolomic and proteomic studies may shed light about the role
of QS in bacterial physiology under in vivo-like conditions. In
addition, the utilization of new technologies like microfluidics
such as cell culture chips (organ-on-a-chip) would enable the
interrogation of the roles of signaling, social cheating, mass
transfer, and spatial organization in well-defined geometries,
which is virtually impossible to asses at this moment using animal
models.
Importantly, additional research about the ways P. aeruginosa
may achieve resistance against QQ is needed in order to generate
effective combination therapies less prone to the selection
of resistance. One possibility is to exploit the fact that QS
interference renders P. aeruginosa more sensitive to stress,
including antibiotics and the effects of the immune system; hence,
it is attractive to test if the combination of QS interference,
antibiotic therapies and immunotherapy to improve the outcome
of the therapies.
Another area of research that should be encouraged is the
role of QS independent virulence factors and those negatively
regulated by QS such as TTSS in infections and the effect of
QS interference on these virulence determinants. Also, study of
QS networks and the-virulence of environmental and clinical
strains is needed since current evidence indicates these are highly
variable (Grosso-Becerra et al., 2014; Garcia-Contreras et al.,
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2015b) and that a specific QQ compound will not always be
effective against all clinical strains. Also, more effort should be
devoted to the study of the implementation of these therapies,
since most of them are able to attenuate infections when the
QQ compound is administrated shortly before the inoculation
(having possible prophylactic effects), but the value of such
therapies as a possible cure for an established infection should
be better addressed.
Taking the available evidence together, it seems QS
interference may be a valuable tool to combat P. aeruginosa
infections; however, using QS inhibition as the sole therapy
may not be an efficient strategy due several potential drawbacks.
Hence, before QSI applications are used in the clinic, it is
advisable to improve our current understanding of P. aeruginosa
virulence with an emphasis on clinical strains and also on further
defining the roles of QS in the physiology of this remarkable
complex pathogen.
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